With better risk stratification, clinicians may be able to optimize medical management of patients with chronic HBV who don’t ...

SBRT showed superiority over radiofrequency ablation in local progression-free survival and tumor control in small HCC but ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...

CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma.

The following is a summary of “Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Researchers examined survival outcomes based on recipient-donor sex constellation after liver transplant for liver cancer.

Liver cancer is the fastest rising cancer killer in Britain and below a nurse revealed the four symtoms she experienced ...

Scientists have made a discovery which could lead to the first change in standard liver cancer treatment in 20 years. Two ...

Marissa Antonio was 39-years-old when she was diagnosed with a 19cm liver tumour - and the nurse went on to issue a warning ...

More than half of patients will die within 12 months of the six most fatal cancers, says new data. Here’s how to reduce the ...